Showing results (391-400 of 464) with videos related to

Sort By:
Pageof 47
CA: a Cancer Journal for Clinicians|May 23, 2019
The current state of molecular testing in the treatment of patients with solid tumors, 2019Wafik S El-Deiry, Richard M Goldberg, Heinz-Josef Lenz, et al.
Cancer Cell|July 7, 2007
Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced deathM Stacey Ricci, Seok-Hyun Kim, Kazuhiro Ogi, et al.
International Journal of Molecular Sciences|July 14, 2023
GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal CancerKelsey E Huntington, Anna D Louie, Praveen R Srinivasan, et al.
Cancer Treatment Reviews|December 2, 2025
Cellular senescence: A novel mechanism of therapeutic resistance in prostate cancerClaire Lin, Matthew J Hadfield, Amol Rathore, et al.
Oncotarget|July 21, 2026
WIN-MTB-2024017 - WIN International Molecular Tumor Board: A 48-year-old female with multiple primary cancersWafik S El-Deiry, Alberto Hernando-Calvo, Don Dizon, et al.
Oncotarget|October 6, 2017
Application of 3D tumoroid systems to define immune and cytotoxic therapeutic responses based on tumoroid and tissue slice culture molecular signaturesNiklas K Finnberg, Prashanth Gokare, Avital Lev, et al.
Cancer Research Communications|November 13, 2025
BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Andre L De Souza, Matthew J Hadfield, Shaolei Lu, et al.
Cell Cycle (Georgetown, Tex.)|May 11, 2017
Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212Jessica Wagner, Christina Leah Kline, Marie D Ralff, et al.
Journal of Gastrointestinal Oncology|November 18, 2021
Molecular characterization of squamous cell carcinoma of the anal canalSamantha A Armstrong, Rita Malley, Hongkun Wang, et al.
BMJ Oncology|January 31, 2025
Molecular and immune landscape of tumours in geriatric patients with non-small cell lung cancer, melanoma and renal cell carcinomaKhalil Choucair, Andrew Elliott, Matthew James Oberley, et al.
Pageof 47